Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PBMs
PBMs
Competition declines among PBM middlemen, analysis finds
Competition declines among PBM middlemen, analysis finds
Benefits Pro
PBMs
competition
AMA
Flag link:
Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Medical Marketing and Media
PBMs
biosimilars
Humira
Flag link:
PhRMA hits out at PBMs as lurking middlemen in latest ad
PhRMA hits out at PBMs as lurking middlemen in latest ad
Medical Marketing and Media
PhRMA
PBMs
lobbying
DTC advertising
Flag link:
Blue Shield of California looks to cut reliance on CVS, taps Amazon
Blue Shield of California looks to cut reliance on CVS, taps Amazon
Yahoo/Reuters
Blue Shield
insurers
California
CVS Health
PBMs
Amazon
Mark Cuban Cost Plus Drugs
Flag link:
U.S. Appeals Court invalidates significant components of Oklahoma law governing PBMs
U.S. Appeals Court invalidates significant components of Oklahoma law governing PBMs
Miller & Chevalier
PBMs
ERISA
Oklahoma
legal
Flag link:
For 2023, Five For-Profit Retailers and PBMs Dominate an Evolving 340B Contract Pharmacy Market
For 2023, Five For-Profit Retailers and PBMs Dominate an Evolving 340B Contract Pharmacy Market
Drug Channels
340B
drug pricing
CVS Health
Walgreens
Cigna
Express Scripts
Unitedhealth Group
OptumRx
Walmart
PBMs
Flag link:
House lawmakers, PBM lobby spar over committee hearing
House lawmakers, PBM lobby spar over committee hearing
BioPharma Dive
PBMs
legislation
drug pricing
Flag link:
On heels of Amgen lawsuit, FTC broadens investigation of PBMs
On heels of Amgen lawsuit, FTC broadens investigation of PBMs
BioPharma Dive
FTC
PBMs
Ascent Health Services
Zinc Health Services
Flag link:
Senate health committee seeks to rein in drug prices with four new bills
Senate health committee seeks to rein in drug prices with four new bills
BioSpace
Senate
drug pricing
generics
PBMs
legislation
Flag link:
What you need to know about pharma, PBM execs testifying on insulin prices
What you need to know about pharma, PBM execs testifying on insulin prices
Medical Marketing and Media
PBMs
insulin
diabetes
drug pricing
Sanofi
Novo Nordisk
Eli Lilly
Flag link:
Sanders, Cassidy reach deal to increase access to generic prescription drugs, reform PBMs
Sanders, Cassidy reach deal to increase access to generic prescription drugs, reform PBMs
Fierce Healthcare
legislation
PBMs
generics
Senate
Flag link:
Four Trends That Will Pop the $250 Billion Gross-to-Net Bubble—and Transform PBMs, Market Access, and Benefit Design
Four Trends That Will Pop the $250 Billion Gross-to-Net Bubble—and Transform PBMs, Market Access, and Benefit Design
Drug Channels
drug pricing
generics
PBMs
Flag link:
A sign of what's coming? Presidential hopeful DeSantis targets PBMs and pharma transparency
A sign of what's coming? Presidential hopeful DeSantis targets PBMs and pharma transparency
Endpoints
PBMs
transparency
Ron DeSantis
drug pricing
Flag link:
House oversight chair calls for investigation into PBMs' tactics to increase drug costs
House oversight chair calls for investigation into PBMs' tactics to increase drug costs
Endpoints
congress
PBMs
Flag link:
PBM trade group ad campaign hits back at drugmakers over prescription drug prices
PBM trade group ad campaign hits back at drugmakers over prescription drug prices
Medical Marketing and Media
PhRMA
PBMs
drug pricing
Flag link:
Senate begins quest to demystify PBMs' practices as it mulls legislation
Senate begins quest to demystify PBMs' practices as it mulls legislation
Endpoints
Senate
PBMs
Flag link:
Years after the first US biosim launches, doctors still have their concerns: survey
Years after the first US biosim launches, doctors still have their concerns: survey
Fierce Pharma
biosimilars
PBMs
physicians
AbbVie
Humira
Amgen
Amjevita
Flag link:
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Fierce Pharma
Novartis
Vas Narasimhan
PhRMA
Inflation Reduction Act
PBMs
small molecule drugs
Flag link:
PBMs likely to be a focus in 118th Congress
PBMs likely to be a focus in 118th Congress
Roll Call
PBMs
congress
drug pricing
Flag link:
The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars
The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars
Drug Channels
PBMs
Caremark
CVS Health
Express Scripts
Cigna
OptumRx
United Health
formularies
insulin
biosimilars
Humira
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »